MegaPro Biomedical Co., Ltd Stock Price

TPEX:6827 Community·NT$776.7m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

6827 Share Price Performance

NT$0

-14.00 (-100.00%)

NT$0

-14.00 (-100.00%)

NT$0

Wed, 24 Dec 25

Share Pricen/a

6827 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks

0 Rewards

View Full Analysis

MegaPro Biomedical Co., Ltd Key Details

Last Reported Earnings

n/a

Next Reporting Earnings

n/a

: 0
: 0%
: 0%
: 0%

View Full Analysis

About 6827

Founded: 2014
Employees: n/a
CEO: Jassy Wang
WebsiteView website: www.megaprobio.com

MegaPro Biomedical Co., Ltd, a biotech company, focuses on the development of nano drugs. It also develops MPB-1523, an IOP injection that is in Phase II clinical trial for use in the treatment of hepatocellular carcinoma; and MPB-1514, an iron injection that is in Phase II clinical trial for use in the treatment of iron deficiency anemia, as well as MPB-1734, an anti-cancer drug that is in preclinical trial for the treatment of malignant tumor. The company was founded in 2014 and is based in Zhubei, Taiwan.